Study confirms the low likelihood that SARS-CoV-2 on hospital surfaces is infectious

A new study by UC Davis researchers confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces is infectious. The study, published June 24 in PLOS ONE, is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs. “Our team was the first to demonstrate that SARS-CoV-2 virus sequences could be identified…

Details

Controversies and consensus in thyroid cancer care

IMAGE: Publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management… view more  Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, June 24, 2021—The American Thyroid Association, the European Association of Nuclear Medicine, the European…

Details

Sleeper cells: Newly discovered stem cell resting phase could put brain tumors to sleep

IMAGE: By analyzing brain stem cell data, Assistant Professor Christopher Plaisier and biomedical engineering doctoral student Samantha O’Connor saw the phases of the cell cycle mapped out in more detail than… view more  Credit: Christopher Plaisier/ASU Christopher Plaisier, an assistant professor of biomedical engineering in the Ira A. Fulton Schools of Engineering at Arizona State University,…

Details

Loss of circadian regulation allows for increase in glucose production during lung cancer

IMAGE: During lung cancer progression and the corresponding development of cachexia, circadian control of glucose production is disrupted, resulting in increased levels of glucose from the liver. These findings illustrate a… view more  Credit: UCI School of Medicine Irvine, CA – June 25, 2021 – New research from the University of California, Irvine reveals how the…

Details

Mayo Clinic researchers study potential new CAR-T cell therapy for multiple myeloma

ROCHESTER, Minn. — Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. Their findings were published on Friday, June 24, in The Lancet. “CAR-T cell therapy is a type of immunotherapy that involves harnessing the power of a person’s own immune…

Details

Research underway to find tools for caregivers of trauma survivors for anxiety, stress

An early intervention developed for caregivers of patients with serious illnesses or injuries will be tested by researchers at The University of Texas Health Science Center at Houston (UTHealth). “In the case of serious injury, chronic illness, or diagnoses that impact patients’ abilities to live and function independently, a loved one often takes on the…

Details